← Leaderboards
Kevin James Downes
Children'S Hosp Of Philadelphia
$5,128,443
Attributed
$7,258,847
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,258,847 · 5
By mechanism
R01$5,992,592 · 2
K23$746,790 · 1
R34$308,000 · 1
T32$211,465 · 1
Top collaborators
- Marc Howard Scheetz5 shared
- Erik Allen Jensen1 shared
- Walter K. Kraft1 shared
- Scott A. Waldman1 shared
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Scott L Weiss$5,440,217
- Frances B Balamuth$3,775,956
- Julie C. Hollows Fitzgerald$1,168,325
- Sara Bonamo Demauro$17,178,971
- Susan Hintz$556,797
Others in their field
Other Emerging Leaders on “Childhood”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,207,652
- Leonard Freedman · Leidos Biomedical Research, Inc.$73,356,290
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Gina Montealegre · Leidos Biomedical Research, Inc.$19,781,641
- Lynn Briscoe · Leidos Biomedical Research, Inc.$18,486,552
Research focus
ChildhoodDoseBloodDrug KineticsAntibioticsChildInfectionMortalityPharmacokinetic ModelCritically Ill ChildrenSamplingRisk FactorsAntibiotic TherapyPediatric Intensive Care UnitsClinical TrialsFutureToxic EffectDrug MonitoringBiological MarkersEnrollmentProspective StudiesModels And SimulationRenal FunctionVancomycin
Grant awards (15)
Assessment of MODS and Personalized Exposures of Antibiotics$674,259
R01 · FY2025 · HD · contact PI
PediatRic sEpsiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) study$669,906
R01 · FY2025 · HD · contact PI
Clinical Pharmacology Training Program$211,465
T32 · FY2025 · HD
PediatRic sEpsiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) study$783,342
R01 · FY2024 · HD · contact PI
Assessment of MODS and Personalized Exposures of Antibiotics$707,539
R01 · FY2024 · HD · contact PI
PediatRic sEpsiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) study$868,490
R01 · FY2023 · HD · contact PI
Assessment of MODS and Personalized Exposures of Antibiotics$742,800
R01 · FY2023 · HD · contact PI
Phase 1 trial of inhaled tobramycin in very preterm infants with bronchopulmonary dysplasia$308,000
R34 · FY2023 · HL · contact PI
Assessment of MODS and Personalized Exposures of Antibiotics$744,885
R01 · FY2022 · HD · contact PI
Optimizing Vancomycin Therapy in Children$149,358
K23 · FY2022 · HD · contact PI
Assessment of MODS and Personalized Exposures of Antibiotics$801,371
R01 · FY2021 · HD · contact PI
Optimizing Vancomycin Therapy in Children$149,358
K23 · FY2021 · HD · contact PI
Optimizing Vancomycin Therapy in Children$149,358
K23 · FY2020 · HD · contact PI
Optimizing Vancomycin Therapy in Children$149,358
K23 · FY2019 · HD · contact PI
Optimizing Vancomycin Therapy in Children$149,358
K23 · FY2018 · HD · contact PI